Miller JS - Search Results

1

Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.

Shrestha B, Walton K, Reff J, Sagatys EM, Tu N, Boucher J, Li G, Ghafoor T, Felices M, Miller JS, Pidala J, Blazar BR, Anasetti C, Betts BC, Davila ML. Shrestha B, et al. Among authors: miller js. J Clin Invest. 2020 Sep 1;130(9):4652-4662. doi: 10.1172/JCI135754. J Clin Invest. 2020. PMID: 32437331 Free PMC article.

2

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

Enright H, Davies SM, DeFor T, Shu X, Weisdorf D, Miller W, Ramsay NK, Arthur D, Verfaillie C, Miller J, Kersey J, McGlave P. Enright H, et al. Blood. 1996 Jul 15;88(2):714-20. Blood. 1996. PMID: 8695820 Free article.

3

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J Jr, Burns LJ. Miller JS, et al. Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44. Biol Blood Marrow Transplant. 1997. PMID: 9209739 Clinical Trial.

4

Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.

Miller JS, Tessmer-Tuck J, Blake N, Lund J, Scott A, Blazar BR, Orchard PJ. Miller JS, et al. Exp Hematol. 1997 Oct;25(11):1140-8. Exp Hematol. 1997. PMID: 9328450

5

Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.

Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P. Weisdorf D, et al. Biol Blood Marrow Transplant. 1997 Oct;3(4):217-23. Biol Blood Marrow Transplant. 1997. PMID: 9360784 Clinical Trial.

6

Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor.

Orchard PJ, Blazar BR, Burger S, Levine B, Basso L, Nelson DM, Gordon K, McIvor RS, Wagner JE, Miller JS. Orchard PJ, et al. Among authors: miller js. Hum Gene Ther. 2002 May 20;13(8):979-88. doi: 10.1089/10430340252939087. Hum Gene Ther. 2002. PMID: 12031130

7

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.

Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, Velardi A, Blazar BR. Davies SM, et al. Among authors: miller js. Blood. 2002 Nov 15;100(10):3825-7. doi: 10.1182/blood-2002-04-1197. Epub 2002 Jul 5. Blood. 2002. PMID: 12393440 Free article.

8

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.

Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D. Anderson D, et al. Biol Blood Marrow Transplant. 2003 Jan;9(1):52-9. doi: 10.1053/bbmt.2003.50000. Biol Blood Marrow Transplant. 2003. PMID: 12533742 Free article.

9

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Barker JN, et al. Among authors: miller js. Blood. 2003 Sep 1;102(5):1915-9. doi: 10.1182/blood-2002-11-3337. Epub 2003 May 8. Blood. 2003. PMID: 12738676 Free article. Clinical Trial.

10

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS. Burns LJ, et al. Among authors: miller js. Bone Marrow Transplant. 2003 Jul;32(2):177-86. doi: 10.1038/sj.bmt.1704086. Bone Marrow Transplant. 2003. PMID: 12838283 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,143 results

Search Page

Filters